Novartis to pay $370 million to settle claims it paid kickbacks for drug referrals | Healthcare Finance News
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
2021 Novartis Multicultural Teen Corporate Mentoring Program Selects 26 Students from Hanover Park | East Hanover/Florham Park, NJ News TAPinto
Rx Digital Marketing
Lilly-Incyte drug reduces eczema symptoms in treatment-resistant patients | S&P Global Market Intelligence
A middle-aged woman with nausea, weight loss, and orthostatic hypotension | Neurology
Novartis links up with Mayo Clinic spinout Anumana to develop ECG-reading AI
Pancreatic Cancer Action Network Adaptive Clinical Trial Adds New Investigational Treatment and Additional Sites - Pancreatic Cancer Action Network
Emirates Dermatology Society And Novartis Launch 'Skin To Live In' A Groundbreaking Campaign For People Living With Psoriasis - Health Magazine
AI and 10 seconds of voice can screen for diabetes, new Mayo Clinic journal study reveals - PharmaLive
Fundación Signo on X: "https://t.co/2eMh5pMGvt" / X
Healthcare Industry News Weekly Wrap-Up: October 6, 2023 | Vault Bioventures
Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients - Mayo Clinic News Network
Inclisiran Reduced LDL-C in Obese Patients | DAIC
Novartis, Propeller Health co-package new asthma treatment | MobiHealthNews
Novartis, Sandoz recall 12 medications over packaging concerns | Fox 8 Cleveland WJW
Anumana and Novartis Collaborate To Deploy AI That Detects Heart Disease